This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Perkinelmer Health Sciences, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012-2014.
Company Filing History:
1 out of 296 
1 out of 3,688 
Years Active: 2012-2014
Title: Les Jones: Innovator in RSV Research
Introduction
Les Jones is a notable inventor based in Peachtree City, GA (US). He has made significant contributions to the field of medical research, particularly in the area of respiratory syncytial virus (RSV) infection and immunity. With a total of 2 patents, his work has the potential to impact the treatment and prevention of RSV disease.
Latest Patents
Les Jones's latest patents focus on compositions and methods for modulating RSV infection and immunity. These patents provide innovative approaches for the treatment or prevention of RSV disease by targeting specific amino acid sequences in the RSV G glycoprotein. The chemokine motif defined as C-X-X-X-C (or CX3C) is identified as essential in causing RSV infection and disease. By interfering with this motif, such as through the administration of a modified vaccine or blocking molecules, the prevention or treatment of RSV infection can be achieved.
Career Highlights
Throughout his career, Les Jones has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and PerkinElmer Health Sciences, Inc. His work in these institutions has allowed him to contribute to significant advancements in medical research.
Collaborations
Les has collaborated with esteemed colleagues, including Ralph A. Tripp and Larry J. Anderson. These partnerships have further enriched his research and innovation in the field.
Conclusion
Les Jones is a dedicated inventor whose work in RSV research showcases his commitment to improving public health. His innovative patents and collaborations highlight the importance of continued research in combating viral infections.